Fundz

Racura Oncology

Sydney, New South Wales, Australia · Biotechnology, Health Care, Medical

Racura Oncology is a biopharmaceutical company focused on developing innovative treatments for cancer. The company is advancing several clinical programs, notably in Acute Myeloid Leukaemia and non-small cell lung cancer. Racura is also exploring treatments aimed at cardioprotection in solid tumor patients. With significant fundraising success, Racura is positioned to enhance its clinical trials.

Key facts

Headquarters
Sydney, New South Wales, Australia
Employees
17
Industries
Biotechnology, Health Care, Medical
Status
Private
Website
racuraoncology.com
LinkedIn
Company page

Recent activity at Racura Oncology

Racura Oncology funding history

DateRoundAmount
Jun 2026Funding Round$34.3M

Leadership

  • Serge Scrofani, Non Executive Director
  • Michael Kelso, Vice President of Research

Verified email and direct lines for Racura Oncology’s decision-makers are on Fundz. See plans

Racura Oncology in the news

Companies similar to Racura Oncology

About Racura Oncology: questions and answers

What does Racura Oncology do?

Racura Oncology is a biopharmaceutical company focused on developing innovative treatments for cancer. The company is advancing several clinical programs, notably in Acute Myeloid Leukaemia and non-small cell lung cancer. Racura is also exploring treatments aimed at cardioprotection in solid tumor patients. With significant fundraising success, Racura is positioned to enhance its clinical trials.

Where is Racura Oncology headquartered?

Racura Oncology is headquartered in Sydney, New South Wales, Australia.

How many employees does Racura Oncology have?

Racura Oncology has about 17 employees.

Has Racura Oncology raised funding?

Yes. Fundz has recorded 1 funding event for Racura Oncology. The most recent, Funding Round of $34.3M, was in Jun 2026.

Who leads Racura Oncology?

Michael Kelso is a Vice President of Research at Racura Oncology.

What is the latest news on Racura Oncology?

On Jun 17, 2026, Racura Oncology raises $34.3 million in a funding round to advance its clinical programs in cancer treatment.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Racura Oncology across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.